000 | 05738nam a22005775i 4500 | ||
---|---|---|---|
001 | 978-3-319-72799-8 | ||
003 | DE-He213 | ||
005 | 20210201191502.0 | ||
007 | cr nn 008mamaa | ||
008 | 180130s2018 gw | s |||| 0|eng d | ||
020 |
_a9783319727998 _9978-3-319-72799-8 |
||
050 | 4 | _aQR46 | |
072 | 7 |
_aMMFM _2bicssc |
|
072 | 7 |
_aMED052000 _2bisacsh |
|
072 | 7 |
_aMKFM _2thema |
|
082 | 0 | 4 |
_a616.9041 _223 |
245 | 1 | 0 |
_aUpdates on Clostridium difficile in Europe _h[electronic resource] : _bAdvances in Microbiology, Infectious Diseases and Public Health Volume 8 / _cedited by Paola Mastrantonio, Maja Rupnik. |
250 | _a1st ed. 2018. | ||
264 | 1 |
_aCham : _bSpringer International Publishing : _bImprint: Springer, _c2018. |
|
300 |
_aVIII, 261 p. 25 illus., 16 illus. in color. _bonline resource. |
||
336 |
_atext _btxt _2rdacontent |
||
337 |
_acomputer _bc _2rdamedia |
||
338 |
_aonline resource _bcr _2rdacarrier |
||
347 |
_atext file _bPDF _2rda |
||
490 | 1 |
_aAdvances in Microbiology, Infectious Diseases and Public Health, _x2365-2675 ; _v1050 |
|
500 | _aAcceso multiusuario | ||
505 | 0 | _aForeword (P. Mastrantonio and M. Rupnik) -- Economic burden of CDI in European countries (E. Reigadas and E. Bouza) -- The need for European surveillance of CDI(C. Wiuff, A.Lan Banks, F. Fitzpatrick, L. Cottom) -- Diagnostic guidance for C. difficile infections (M.J.T. Crobach,A.Baktash, N. Duszenko, E.J. Kuijper) -- Ribotypes and new virulent strains across Europe (J. Couturier, K. Davies, C. Gateau, F. Barbut) -- Comparative genomics of C. difficile strains (S. Janezic, J.R.Garneau, M. Monot) -- Cellular uptake and mode-of-action of Clostridium difficile toxins (P.Papatheodorou, H. Barth, N. Minton, K. Aktories) -- Clostridium difficile biofilm (C. Vuotto, G. Donelli, A. Buckley, C. Chilton) -- European practice for CDI treatment (F. Fitzpatrick, M. Skally, M. Brady, K. Burns, C. Rooney, M.H. Wilcox) -- Antibiotic resistances of Clostridium difficile (P. Spigaglia, P. Mastrantonio, F. Barbanti) -- Probiotics for prevention and treatment of Clostridium difficile infection (L. Valdés-Varela, M. Gueimonde, P. Ruas-Madiedo) -- Faecal microbiota transplantation as emerging treatment in European countries (M. Maida, J. McIlroy, G. Ianiro, G. Cammarota) -- Immunization strategies against Clostridium difficile (J.F. Bruxelle, S. Péchiné, A. Collignon) -- Non-human C. difficile reservoirs and sources: animals, food, environment (C. Rodriguez Diaz, C. Seyboldt , M. Rupnik) -- The ESCMIDStudy Group for Clostridium difficile: history, role and perspectives (J.E. Coia and E.J. Kuijper). | |
520 | _aThis book outlines the currently available clinical, epidemiological and experimental data on Clostridium difficile infection (CDI) with special emphasis on studies and results achieved in Europe. The incidence and severity of CDI has increased significantly over the last decade, and the book explains why C. difficile, recently reclassified as Clostridioides difficile, remains a significant challenge, also from economic perspective, to health care systems all over the world. The different reservoirs of this ubiquitous microorganism are reviewed as well as the different factors contributing to its virulence, such as toxins and biofilm formation. The rapid evolution of antibiotic resistance is clearly a concern and in a specific way can influence the CDI epidemiology. Additionally, new emerging strains and comparative genomics studies are discussed for their relevance from epidemiological and evolutionary point of view. The book also gives an overview on diagnostics, therapy and surveillance, all of which are still challenging. Therefore, a closer look is taken on the effect of probiotics as an alternative to antibiotics, for prevention and treatment of CDI. Fecal transplantation from healthy donors, passive immunotherapies and vaccines for patients with recurrences are also discussed in dedicated chapters. The book closes with a summary of the history and the achievements of the European Society of Clinical Microbiology and Infectious Diseases Study Group for Clostridium difficile (ESGCD) written by the current and past presidents of the Society. It is the aim of this book to raise awareness on CDI and to disseminate updated information on its prevention, diagnosis and treatment. | ||
541 |
_fUABC ; _cTemporal ; _d01/01/2021-12/31/2023. |
||
650 | 0 | _aMedical microbiology. | |
650 | 0 | _aInfectious diseases. | |
650 | 0 | _aMicrobiology. | |
650 | 1 | 4 |
_aMedical Microbiology. _0https://scigraph.springernature.com/ontologies/product-market-codes/B16003 |
650 | 2 | 4 |
_aInfectious Diseases. _0https://scigraph.springernature.com/ontologies/product-market-codes/H33096 |
650 | 2 | 4 |
_aMicrobiology. _0https://scigraph.springernature.com/ontologies/product-market-codes/L23004 |
700 | 1 |
_aMastrantonio, Paola. _eeditor. _4edt _4http://id.loc.gov/vocabulary/relators/edt |
|
700 | 1 |
_aRupnik, Maja. _eeditor. _4edt _4http://id.loc.gov/vocabulary/relators/edt |
|
710 | 2 | _aSpringerLink (Online service) | |
773 | 0 | _tSpringer Nature eBook | |
776 | 0 | 8 |
_iPrinted edition: _z9783319727981 |
776 | 0 | 8 |
_iPrinted edition: _z9783319728001 |
776 | 0 | 8 |
_iPrinted edition: _z9783319892108 |
830 | 0 |
_aAdvances in Microbiology, Infectious Diseases and Public Health, _x2365-2675 ; _v1050 |
|
856 | 4 | 0 |
_zLibro electrónico _uhttp://148.231.10.114:2048/login?url=https://doi.org/10.1007/978-3-319-72799-8 |
912 | _aZDB-2-SBL | ||
912 | _aZDB-2-SXB | ||
942 | _cLIBRO_ELEC | ||
999 |
_c244008 _d244007 |